TrialThe Lancet. Neurology2013

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.

John Zajicek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.